EQUR Stock Overview
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
E-Qure Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.05 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.76% |
| 5 Year Change | -99.69% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EQUR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | n/a | -3.7% | 19.3% |
Return vs Industry: Insufficient data to determine how EQUR performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how EQUR performed against the US Market.
Price Volatility
| EQUR volatility | |
|---|---|
| EQUR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EQUR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine EQUR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Ohad Goren | www.e-qure.com |
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
E-Qure Corp. Fundamentals Summary
| EQUR fundamental statistics | |
|---|---|
| Market cap | US$15.12k |
| Earnings (TTM) | -US$726.18k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs EQUR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EQUR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$726.18k |
| Earnings | -US$726.18k |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EQUR perform over the long term?
See historical performance and comparison